Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03618550
Title Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications
Therapies
Age Groups: child | senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Miami RECRUITING Miami Florida 33136 United States Details
Memorial Sloan Kettering Basking Ridge RECRUITING Basking Ridge New Jersey 07920 United States Details
Memorial Sloan Kettering Monmouth RECRUITING Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen RECRUITING Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Cancer Center @ Commack RECRUITING Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester RECRUITING Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
Memorial Sloan Kettering Nassau RECRUITING Uniondale New York 11553 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field